Synthetic Biology – Products

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization.

Investment to expand cell line development capabilities and accelerate customer workflows, as part of its diverse and tailored antibody solutions.

Sphere Fluidics has announced updates to its flagship platform, Cyto-Mine®, enabling it to be compliant with current Good Manufacturing Practice regulations enforced by the US FDA.

Meissa Vaccines announced it has entered into a manufacturing agreement with Exothera S.A. delivering customized process development and GMP manufacturing services for vaccines, viral vectors and nucleic acids.

Sphere Fluidics announced Biosyntia, a biotechnology company focused on synthetic biology and metabolic engineering, has adopted the Pico-Mine® platform within its workflows.

New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation.

Sphere Fluidics announced the introduction of new branding to align with its ambitious global commercial growth strategy.

SCIEX, celebrates the opening of the Echo® MS Center of Excellence.

Ansa Biotechnologies, Inc., announced that it has synthesized and delivered complex clonal DNA sequences to multiple customers participating in its Early Access Program.

Telesis Bio Inc. has announced the availability of its BioXp® Select mRNA Synthesis Kit.